SABBY MANAGEMENT, LLC 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-01-10 2:47 pm Sale | 2022-12-31 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 796,706 11.000% | -434,124 (-35.27%) | Filing |
2022-01-04 9:13 pm Purchase | 2021-12-31 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 1,230,830 11.000% | 230,830 (+23.08%) | Filing |
2021-12-06 5:11 pm Purchase | 2021-12-02 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 1,000,000 11.000% | 1,000,000 (New Position) | Filing |